<div id="readability-page-1"><p>Lake Street analyst Brooks O’Neil reiterated a Buy rating on Harrow Health today and set a price target of $70.00.</p><h3>Meet Your ETF AI Analyst</h3><ul><li> Discover how TipRanks' <i>ETF</i> AI Analyst  can help you make smarter investment decisions </li><li>   Explore ETFs TipRanks' users love  and see what insights the <b><i>ETF</i> AI Analyst</b> reveals about the ones you follow.</li></ul> <p>According to TipRanks, O’Neil is a 2-star analyst with an average return of <span>0.2%</span> and a 39.88% success rate.</p> <p>In addition to Lake Street, Harrow Health also received a Buy from Craig-Hallum’s Chase Knickerbocker in a report issued on November 12. However, on the same day, TR | OpenAI – 4o reiterated a Hold rating on Harrow Health (NASDAQ: HROW).</p></div>

HROW

<p>Lake Street analyst Brooks O’Neil reiterated a Buy rating on Harrow Health with a price target of $70.00. O’Neil is a 2-star analyst with an average return of 0.2% and a 39.88% success rate. Craig-Hallum’s Chase Knickerbocker also issued a Buy rating, while TR reiterated a Hold rating on Harrow Health.</p>

Harrow Health (HROW) Receives a Buy from Lake Street